Neuralink (Series D)
Funding Details
Awarder
Inbox
Date Award
May 27, 2025
Vertical
Neurotechnology
Premoney Valuation
$8,500,000,000
Valuation
$9,000,000,000
Funding Amount
$600,000,000
Company Info
Traction
Neuralink has successfully implanted three chips into patients, including a man with ALS who demonstrated the ability to speak using the chip.
Founders
Elon Musk
Market
Healthcare
Location
USA
Company Description

Neuralink is a brain-mapping company that has developed technology to implant chips into the brains of patients who are paralyzed or unable to speak, enabling them to communicate through thought.

Links